Trials of an experimental HIV vaccine will begin on 24 human volunteers in South Africa, where 4.7 million people, or 11 percent of the population, are HIV-positive, Associated Press reported this week. The treatment, which is also being tested in the United States, is one of about two dozen potential vaccines being tested on about 12,000 human volunteers worldwide.